FCP
AMGN icon

Fidelis Capital Partners’s Amgen AMGN Stock Holding History

Fidelis Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59M Sell
7,357
-906
-11% -$323K 0.18% 103
2025
Q4 		$2.7M Buy
8,263
+708
+9% +$225K 0.2% 95
2025
Q3 		$2.13M Buy
7,555
+2,904
+62% +$842K 0.17% 104
2025
Q2 		$1.32M Buy
4,651
+28
+0.6% +$7.93K 0.12% 138
2025
Q1 		$1.3M Buy
4,623
+14
+0.3% +$4.13K 0.14% 121
2024
Q4 		$1.33M Buy
4,609
+160
+4% +$47.5K 0.13% 131
2024
Q3 		$1.4M Buy
4,449
+90
+2% +$29.4K 0.17% 113
2024
Q2 		$1.36M Buy
4,359
+465
+12% +$137K 0.19% 90
2024
Q1 		$1.11M Buy
3,894
+325
+9% +$95.1K 0.17% 113
2023
Q4 		$1.03M Buy
3,569
+753
+27% +$205K 0.23% 90
2023
Q3 		$757K Buy
2,816
+391
+16% +$97.6K 0.26% 89
2023
Q2 		$538K Buy
2,425
+157
+7% +$36.4K 0.2% 121
2023
Q1 		$536K Buy
2,268
+1,513
+200% +$371K 0.23% 111
2022
Q4 		$204K Buy
+755
New +$202K 0.24% 110

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelis Capital Partners's AMGN Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $323K and leaving 7,357 shares worth $2.59M. The position accounts for 0.18% of the portfolio, ranked #103.

Fidelis Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.7M in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fidelis Capital Partners held 7,357 shares of Amgen worth $2.59M as of Q1 2026.
  • Fidelis Capital Partners sold 906 Amgen shares in Q1 2026, an estimated $323K.
  • Amgen made up 0.18% of Fidelis Capital Partners's portfolio in Q1 2026, its #103 holding.
  • Fidelis Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Fidelis Capital Partners's Amgen position peaked at $2.7M in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.